ACHV Achieve Life Sciences, Inc. Stock Quote

ACHV [NASD]

Index	-	P/E	-	EPS (ttm)	-8.76	Insider Own	0.48%	Shs Outstand	3.29M	Perf Week	10.67%
Market Cap	52.36M	Forward P/E	-	EPS next Y	-5.30	Insider Trans	0.00%	Shs Float	3.20M	Perf Month	23.42%
Income	-13.20M	PEG	-	EPS next Q	-1.28	Inst Own	21.00%	Short Float	15.11%	Perf Quarter	11.17%
Sales	-	P/S	-	EPS this Y	45.00%	Inst Trans	148.01%	Short Ratio	2.21	Perf Half Y	13.90%
Book/sh	7.81	P/B	1.25	EPS next Y	9.40%	ROA	-64.50%	Target Price	-	Perf Year	-18.68%
Cash/sh	-	P/C	-	EPS next 5Y	-	ROE	-72.10%	52W Range	4.51 - 18.26	Perf YTD	20.37%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-45.07%	Beta	1.55
Dividend %	-	Quick Ratio	13.00	Sales past 5Y	-	Gross Margin	-	52W Low	122.15%	ATR	0.47
Employees	14	Current Ratio	13.00	Sales Q/Q	-	Oper. Margin	-	RSI (14)	72.30	Volatility	5.76% 5.76%
Optionable	No	Debt/Eq	0.00	EPS Q/Q	87.40%	Profit Margin	-	Rel Volume	1.20	Prev Close	9.75
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Nov 12 AMC	Payout	-	Avg Volume	218.57K	Price	10.03
Recom	1.70	SMA20	20.74%	SMA50	19.24%	SMA200	17.15%	Volume	259,909	Change	2.87%

Jan-07-21 05:30AM	Achieve Life Sciences to Present at H.C. Wainwright Virtual BioConnect Conference ACCESSWIRE +8.99%
Dec-07-20 04:05PM	Achieve Life Sciences, Inc. Announces Closing of $17.3 Million Underwritten Public Offering, Including Full Exercise of Overallotment Option PR Newswire +5.39%
04:05PM	Achieve Life Sciences, Inc. Announces Closing of $17.3 Million Underwritten Public Offering, Including Full Exercise of Overallotment Option CNW Group
Dec-03-20 08:00AM	Achieve Life Sciences Announces Pricing of $15 Million Public Offering PR Newswire -5.34%
08:00AM	Achieve Life Sciences Announces Pricing of $15 Million Public Offering CNW Group
Nov-30-20 07:00AM	Achieve Life Sciences Announces Proposed Public Offering PR Newswire -5.27%
07:00AM	Achieve Life Sciences Announces Proposed Public Offering CNW Group
04:08AM	ACHV: The ORCA Has Launched: Target to $50 Zacks Small Cap Research
Nov-24-20 11:26AM	ACHV: Achieve Hosts Smoking Cessation KOL Call Zacks Small Cap Research
Nov-16-20 05:16AM	Is Achieve Life Sciences (NASDAQ:ACHV) In A Good Position To Invest In Growth? Simply Wall St. +6.69%
Nov-12-20 04:05PM	Achieve Reports Financial Results for Third Quarter 2020 and Provides Corporate and Cytisinicline Development Update PR Newswire
04:05PM	Achieve Reports Financial Results for Third Quarter 2020 and Provides Corporate and Cytisinicline Development Update CNW Group
02:30PM	Achieve Life Sciences, Inc. to Host Earnings Call ACCESSWIRE
Oct-29-20 05:30AM	Achieve Life Sciences to Announce Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 12, 2020 PR Newswire
Oct-27-20 05:30AM	Achieve Life Sciences to Host Smoking Cessation Key Opinion Leader Virtual Roundtable on November 17th, 2020 PR Newswire
Oct-08-20 06:30AM	Achieve Life Sciences Announces to Present at the MicroCap Best Ideas Conference, October 13, 2020 ACCESSWIRE +7.17%
Oct-07-20 06:30AM	Achieve Life Sciences Announces Start of Phase 3 ORCA-2 Clinical Trial Evaluating Cytisinicline for Smoking Cessation PR Newswire +7.34%
Sep-30-20 08:00AM	Achieve Life Sciences Announces Appointment of John Bencich to Chief Executive Officer & Dr. Cindy Jacobs to President PR Newswire
08:00AM	Achieve Life Sciences Announces Appointment of John Bencich to Chief Executive Officer & Dr. Cindy Jacobs to President CNW Group
Sep-21-20 06:17AM	ACHV: Achieve Updates and RAUORA Zacks Small Cap Research -9.29%
Sep-18-20 09:30AM	Achieve Announces Presentation of Investigator-Led RAUORA Trial Data Demonstrating Significantly Fewer Side Effects with Higher Quit Rates for Cytisinicline (cytisine) Compared to Chantix® (varenicline) in First Head-to-Head Comparative Study PR Newswire -6.75%
07:00AM	Achieve Life Sciences Announces Results from Evaluation of Cytisinicline (cytisine) versus Chantix® (varenicline) in 5-HT3 Receptor Binding Assay Study PR Newswire
Sep-10-20 05:30AM	Achieve Life Sciences Announces Presentation of Cytisinicline Data at the 20th Annual Society for Research on Nicotine & Tobacco Europe (SRNT-E) Virtual Conference PR Newswire +10.12%
Sep-03-20 05:30AM	Achieve Life Sciences to Present at Upcoming Investor Conferences PR Newswire
Aug-24-20 11:10AM	ACHV: Fourth Quarter Start for ORCA-2 Zacks Small Cap Research -6.04%
Aug-06-20 04:05PM	Achieve Reports Financial Results for Second Quarter 2020 and Provides Update on Cytisinicline Development Program PR Newswire
Jun-30-20 09:33AM	ACHV: RAUORA: Cytisiniclines Superior Side Effect Profile Zacks Small Cap Research
Jun-29-20 08:35AM	Achieve Life Sciences Announces Pricing of $6 Million Registered Direct Offering PR Newswire -6.01%
08:35AM	Achieve Life Sciences Announces Pricing of $6 Million Registered Direct Offering CNW Group
08:30AM	Achieve Announces Successful Results from the Investigator-Initiated RAUORA Head-to-Head Non-Inferiority Clinical Trial Comparing Cytisinicline and Chantix® (varenicline) as a Treatment to Quit Smoking PR Newswire
08:30AM	Achieve Announces Successful Results from the Investigator-Initiated RAUORA Head-to-Head Non-Inferiority Clinical Trial Comparing Cytisinicline and Chantix® (varenicline) as a Treatment to Quit Smoking CNW Group
Jun-05-20 02:49PM	Hedge Funds Nibbling On Achieve Life Sciences, Inc. (ACHV) Insider Monkey
May-29-20 05:54AM	ACHV: When Quitting Gets You to the Finish Line Zacks Small Cap Research
May-14-20 07:30AM	Achieve Reports Financial Results for First Quarter 2020 and Provides Update on Cytisinicline Development Program PR Newswire
May-05-20 08:00AM	Achieve Life Sciences to Announce First Quarter 2020 Financial Results and Host Conference Call and Webcast on May 14, 2020 CNW Group
Apr-30-20 04:50PM	Achieve Life Sciences Announces Private Placement of $1.9 Million PR Newswire
Apr-06-20 05:40AM	ACHV: Extended Treatment May Improve Quit Rates Zacks Small Cap Research
Apr-02-20 08:00AM	Seasoned Biotech Financial Executive, Jay M. Moyes, Joins Sera Prognostics GlobeNewswire
Mar-13-20 08:00AM	Achieve Reports Financial Results for Fourth Quarter and Year-End 2019 and Provides Update on Cytisinicline Development Program PR Newswire -11.79%
08:00AM	Achieve Reports Financial Results for Fourth Quarter and Year-End 2019 and Provides Update on Cytisinicline Development Program CNW Group
Mar-12-20 05:30AM	Achieve Life Sciences Announces Presentation of Additional Cytisinicline Analyses at the Society for Research on Nicotine & Tobacco (SRNT) Annual Meeting PR Newswire -15.86%
Mar-03-20 05:30AM	Achieve Life Sciences to Announce Fourth Quarter and Year-End 2019 Financial Results and Host Conference Call and Webcast on March 13, 2020 CNW Group -5.20%
Feb-06-20 08:00AM	Achieve Life Sciences Announces Agreement with the FreeMind Group to Assist in Securing Non-Dilutive Funding to Evaluate Cytisinicline in Vaping and e-Cigarette Users PR Newswire
Jan-13-20 06:30AM	Achieve Life Sciences, University of Bristol, and Oracle Corporation Announce Study Results Demonstrating Potential for Accelerated Speed of Drug Discovery PR Newswire -7.80%
Dec-23-19 05:31AM	Here's Why We're A Bit Worried About Achieve Life Sciences's (NASDAQ:ACHV) Cash Burn Situation Simply Wall St.
Dec-19-19 04:05PM	Achieve Life Sciences, Inc. Announces Closing of $13.8 Million Underwritten Public Offering, Including Full Exercise of Overallotment Option PR Newswire
04:05PM	Achieve Life Sciences, Inc. Announces Closing of $13.8 Million Underwritten Public Offering, Including Full Exercise of Overallotment Option CNW Group
Dec-17-19 01:06PM	Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering PR Newswire -36.49%
01:06PM	Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering CNW Group
Dec-09-19 05:30AM	Achieve Life Sciences Announces Completion of Meeting with the U.S. Food & Drug Administration (FDA) on Cytisinicline Smoking Cessation Phase 3 Clinical Development Program PR Newswire +14.27%
05:30AM	Achieve Life Sciences Announces Completion of Meeting with the U.S. Food & Drug Administration (FDA) on Cytisinicline Smoking Cessation Phase 3 Clinical Development Program CNW Group
Nov-11-19 10:00AM	ACHV: After Capital Raise Ready for Phase III Zacks Small Cap Research
Nov-06-19 06:30AM	Achieve Reports Financial Results for Third Quarter 2019 and Provides Update on Cytisinicline Development Program PR Newswire -13.93%
06:30AM	Achieve Reports Financial Results for Third Quarter 2019 and Provides Update on Cytisinicline Development Program CNW Group
Oct-31-19 05:30AM	Achieve Life Sciences to Announce Third Quarter 2019 Financial Results and Host Conference Call and Webcast on November 6, 2019 CNW Group
Oct-24-19 07:11AM	What Type Of Shareholder Owns Achieve Life Sciences, Inc.'s (NASDAQ:ACHV)? Simply Wall St.
05:30AM	Achieve Life Sciences Announces Presentation of Cytisinicline Data at Society for Research on Nicotine & Tobacco Oceania (SRNT-O) Inaugural Conference PR Newswire
05:30AM	Achieve Life Sciences Announces Presentation of Cytisinicline Data at Society for Research on Nicotine & Tobacco Oceania (SRNT-O) Inaugural Conference CNW Group
Sep-30-19 05:30AM	Achieve Life Sciences Announces Completion of Maximum Tolerated Dose Study PR Newswire -9.57%
Sep-25-19 06:30AM	ACHV: Post Phase II Investor Day Zacks Small Cap Research
Sep-13-19 05:30AM	Achieve Life Sciences Announces Final Phase 2b ORCA-1 Trial Data Presented at Society for Research on Nicotine & Tobacco Europe (SRNT-E) 19th Annual Conference PR Newswire
Sep-09-19 10:34AM	What Kind Of Share Price Volatility Should You Expect For Achieve Life Sciences, Inc. (NASDAQ:ACHV)? Simply Wall St.
Sep-05-19 05:30AM	Achieve Life Sciences to Host Investor Day on September 20th Including Roundtable Discussion with Smoking Cessation Medical Experts and Final Data from the Phase 2b ORCA-1 Trial PR Newswire +5.71%
Sep-04-19 05:30AM	Achieve Life Sciences Announces Presentations at Upcoming Investor Conferences PR Newswire +5.53%
Aug-26-19 02:30PM	ACHV: SRNT Presentation Next on Agenda Zacks Small Cap Research
10:30AM	ACHV: SRNT Presentation Next on Agenda Zacks Small Cap Research
Aug-08-19 05:39PM	/C O R R E C T I O N -- Achieve Life Sciences, Inc./ PR Newswire +5.71%
04:05PM	Achieve Reports Financial Results for Second Quarter 2019 and Provides Cytisinicline Clinical Development Update CNW Group
Jul-30-19 05:30AM	Achieve Life Sciences to Announce Second Quarter 2019 Financial Results and Host Conference Call and Webcast on August 8, 2019 PR Newswire
05:30AM	Achieve Life Sciences to Announce Second Quarter 2019 Financial Results and Host Conference Call and Webcast on August 8, 2019 CNW Group
Jul-23-19 05:30AM	Achieve Life Sciences Extends Collaboration with the National Institutes of Health to Advance the Development of Cytisinicline for Smoking Cessation PR Newswire
Jul-10-19 10:47AM	Did You Manage To Avoid Achieve Life Sciences's (NASDAQ:ACHV) Painful 55% Share Price Drop? Simply Wall St.
Jun-21-19 10:38AM	Achieve Life Sciences Says Mid-Stage Data For Smoking Cessation Drug Accepted For Presentation At Conference Benzinga
05:30AM	Achieve Life Sciences Announces Phase 2b ORCA-1 Trial Data Accepted for Oral Presentation at Society for Research on Nicotine & Tobacco Europe (SRNT-E) 19th Annual Conference PR Newswire
Jun-12-19 01:00PM	ACHV: ORCA-1 Topline Results and Comparison Zacks Small Cap Research -8.62%
Jun-11-19 07:00AM	Achieve Life Sciences Announces Statistically Significant Improvement in Quit Rates for Simplified Cytisinicline Dosing Schedule in Phase 2b ORCA-1 Dose-Selection Trial PR Newswire -25.26%
07:00AM	Achieve Life Sciences Announces Statistically Significant Improvement in Quit Rates for Simplified Cytisinicline Dosing Schedule in Phase 2b ORCA-1 Dose-Selection Trial CNW Group
Jun-03-19 04:05PM	Achieve Receives $4.2 Million from Exercise of Warrants PR Newswire
04:05PM	Achieve Receives $4.2 Million from Exercise of Warrants CNW Group
May-30-19 02:00PM	ACHV: 1Q:19 Financial & Operational Update Zacks Small Cap Research
05:30AM	Achieve Announces Patent Granted in the U.S. for Novel Formulation of Cytisinicline PR Newswire
May-15-19 04:05PM	Achieve Reports Financial Results for First Quarter 2019 and Provides Cytisinicline Clinical Development Update PR Newswire
04:05PM	Achieve Reports Financial Results for First Quarter 2019 and Provides Cytisinicline Clinical Development Update CNW Group
May-07-19 05:30AM	Achieve Life Sciences to Announce First Quarter 2019 Financial Results and Host Conference Call and Webcast on May 15, 2019 PR Newswire
Apr-26-19 10:00AM	ACHV: Final Enrollee, Final Visit Zacks Small Cap Research +8.21%
Apr-24-19 05:30AM	Achieve Life Sciences Announces Last Subject, Last Visit Completed in Phase 2b ORCA-1 Trial of Cytisinicline for Smoking Cessation PR Newswire
Apr-03-19 05:30AM	Achieve Life Sciences to Present at HC Wainwright Global Life Sciences Conference on April 8, 2019 PR Newswire +5.64%
Apr-02-19 07:30AM	The Daily Biotech Pulse: FDA Nod For ADMA, Regulatory Setback For Apyx, Achieve Life Sciences Smoking Cessation Drug Trial Benzinga
05:30AM	Achieve Life Sciences Announces Successful Completion of the Second and Final DSMC Review of Phase 2b ORCA-1 Trial of Cytisinicline for Smoking Cessation PR Newswire
Mar-25-19 10:00AM	ACHV: Fiscal Year 2018 Operational and Financial Results Zacks Small Cap Research +6.71%
Mar-18-19 08:35AM	What Do the Clinical Updates at Achieve Life Sciences Mean for Cytisinicline ACCESSWIRE +5.32%
05:30AM	Achieve Life Sciences to Present at Oppenheimer's 29th Annual Healthcare Conference on March 20, 2019 PR Newswire
Mar-15-19 04:05PM	Four Healthcare Stocks Picking Up Speed On Friday ACCESSWIRE +22.86%
Mar-14-19 04:05PM	Achieve Reports Financial Results for Year-End 2018 and Provides Cytisinicline Clinical Development Update PR Newswire
Mar-12-19 01:00PM	ACHV: A Reason to Quit is a Reason to Buy Zacks Small Cap Research
Mar-05-19 05:30AM	Achieve Life Sciences to Announce Fourth Quarter and Year-End 2018 Financial Results and Host Conference Call and Webcast on March 14, 2019 PR Newswire
Feb-28-19 09:00AM	Predictive Technology Group Names Jay M. Moyes to Its Board of Directors GlobeNewswire
Feb-25-19 10:30AM	Healthcare Stocks Leading the Sector ACCESSWIRE -19.70%
06:26AM	Could The Achieve Life Sciences, Inc. (NASDAQ:ACHV) Ownership Structure Tell Us Something Useful? Simply Wall St.
Feb-22-19 10:40AM	Four Healthcare Stocks Looking to Close Out a Strong Week ACCESSWIRE +84.36%

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation aids in the United States and internationally. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Bencich John	CFO & COO	Aug 18	Option Exercise	0.00	69	0	174	Aug 19 04:26 PM
JACOBS CINDY	EVP, CMO	Aug 18	Option Exercise	0.00	69	0	209	Aug 19 04:25 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience